When a member of Congress buys or sells stock, people tend to notice. It's like getting a peek at someone's homework, especially when that someone happens to be pretty good at the assignment. Most of the attention goes to the big, flashy names—the so-called Magnificent Seven or other large-cap giants. But sometimes, the more interesting moves are the quiet ones in the corners of the market.
Enter Congressman Tim Moore of North Carolina. He made waves in 2025 for his stock picks, particularly his foray into beaten-down names like Cracker Barrel (CBRL) and some small-cap stocks. Now, he's back with a fresh set of trades for 2026, and once again, he's putting money into companies with smaller market capitalizations. It's the investing equivalent of going back to the same dive bar because you had a good time last time.
According to the latest disclosures, reported by Quiver Quantitative, here's what Moore has been up to:
- Feb. 18: Sold $1,001 to $15,000 in Coinbase Global (COIN) shares
- Feb. 12: Bought $1,001 to $15,000 in Krispy Kreme (DNUT) shares
- Feb. 11: Bought $15,001 to $50,000 in Simply Good Foods (SMPL) shares
- Feb. 5: Bought $1,001 to $15,000 in Genprex Inc (GNPX) shares
- Feb. 3: Bought $15,001 to $50,000 in Simply Good Foods shares
- Jan. 30: Sold $15,001 to $50,000 in AT&T (T) shares
- Jan. 30: Sold $15,001 to $50,000 in Verizon Communications (VZ) shares
- Jan. 23: Bought $15,001 to $50,000 in Harley-Davidson Inc. (HOG) shares
The list shows a mix of activity: selling out of a crypto exchange and two telecom giants, while buying into donuts, motorcycles, and a couple of food and biotech names. But the real story for small-cap watchers is his continued interest in two specific companies.
First, there's Genprex. This is a tiny gene therapy company with a current market capitalization of just $5.2 million. Moore bought shares on three occasions in 2025, totaling between $31,000 and $115,000. Now, in February 2026, he's buying again. It's not a huge position in dollar terms, but when a congressman—especially one with a recent hot hand—keeps going back to the same micro-cap well, people start to wonder what he sees in the water.
The other small-cap play is Simply Good Foods. With a market cap of $1.6 billion, it's bigger than Genprex but still fits the small-cap bill. Moore made two purchases in early February totaling between $30,000 and $100,000. The stock has had a rough run, down 53% over the past 52 weeks and 15% year-to-date in 2026. According to the data, Moore is the first member of Congress to buy the stock in recent years. Buying a stock that's been cut in half over the past year is either a brave contrarian bet or a sign that someone thinks the bad news is already baked in.
This isn't Moore's first rodeo with smaller companies. In 2025, he was noticed for buying shares in Genprex and also in Hyster-Yale Inc (HY), a $680 million market cap lift truck company. More importantly, he was recently crowned the top-performing member of Congress for stock trades in 2025 by Quiver Quantitative. The congressman's portfolio gained 52% last year, dramatically outperforming other members of Congress and the S&P 500's 16.6% gain.
Past performance, as they always say, is no guarantee of future results. But when someone outperforms the market that significantly, and then turns around and buys more of a $5 million market cap company, it's at least worth a raised eyebrow. His trades, particularly in the small and micro-cap space, become a data point for investors to consider—not a recommendation to follow blindly, but a piece of the puzzle in understanding market sentiment and potential opportunities.
So, while everyone else is watching the Magnificent Seven, Congressman Moore is out there browsing the small-cap aisle. Whether he's found a hidden gem or is just making a speculative bet, his moves are a reminder that sometimes the most interesting action isn't in the biggest names on the board.
